4//SEC Filing
Throne Jason 4
Accession 0001610717-23-000279
CIK 0001676725other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 5:23 PM ET
Size
9.7 KB
Accession
0001610717-23-000279
Insider Transaction Report
Form 4
Throne Jason
VP, General Counsel
Transactions
- Sale
Common Stock
2023-09-12$30.01/sh−500$15,005→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-09-12−1,000→ 53,913 totalExercise: $12.86Exp: 2032-02-29→ Common Stock (1,000 underlying) - Exercise/Conversion
Common Stock
2023-09-12$12.86/sh+1,000$12,860→ 1,000 total - Sale
Common Stock
2023-09-12$30.00/sh−500$15,000→ 500 total
Footnotes (2)
- [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 29, 2023.
- [F2]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
IDEAYA Biosciences, Inc.
CIK 0001676725
Entity typeother
Related Parties
1- filerCIK 0001790865
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 5:23 PM ET
- Size
- 9.7 KB